Finasteride Patent Expiration

Finasteride is used for treating male pattern baldness and androgenic alopecia. It was first introduced by Organon Llc A Sub Of Organon And Co in its drug Proscar on Jun 19, 1992. Another drug containing Finasteride is Propecia. 18 different companies have introduced drugs containing Finasteride.


Finasteride Patents

Given below is the list of patents protecting Finasteride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Proscar US5942519 Prevention of precipitated acute urinary retention Oct 23, 2018

(Expired)

Organon
Propecia US5571817 Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] Nov 05, 2013

(Expired)

Organon
Propecia US5547957 Method of treating androgenic alopecia with 5-α reductase inhibitors Oct 15, 2013

(Expired)

Organon
Propecia US5886184 Finasteride processes Nov 19, 2012

(Expired)

Organon
Proscar US5886184 Finasteride processes Nov 19, 2012

(Expired)

Organon



Finasteride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Finasteride Generic API Manufacturers

Several generic applications have been filed for Finasteride. The first generic version for Finasteride was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Jun 19, 2006. And the latest generic version is by Alkem Laboratories Ltd and was approved on Jan 6, 2017.

Given below is the list of companies who have filed for Finasteride generic, along with the locations of their manufacturing plants worldwide.